4.3 Article

Effect of Prophylactic Vaccination with the Membrane-Bound Acid Phosphatase Gene of Leishmania mexicana in the Murine Model of Localized Cutaneous Leishmaniasis

Journal

JOURNAL OF IMMUNOLOGY RESEARCH
Volume 2021, Issue -, Pages -

Publisher

HINDAWI LTD
DOI: 10.1155/2021/6624246

Keywords

-

Categories

Funding

  1. Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico [CVU 636713]
  2. CONACyT, Mexico [CB 2014-240882-M]
  3. Fondo SEP-Cinvestav [193]

Ask authors/readers for more resources

Leishmaniasis, caused by intracellular protozoan parasite Leishmania, is a challenging disease to treat. A potential vaccine candidate, the LmxMBA gene, was identified and tested in a murine model, showing reduced lesion size and parasitic load. Vaccination with pVAX1::LmxMBA induced a T helper 1 response characterized by increased IgG2a/IgG1 ratio and lymphoproliferative response, supporting it as a preventive strategy against L. mexicana infection.
Leishmaniasis is a disease caused by an intracellular protozoan parasite of the genus Leishmania. Current treatments for leishmaniasis are long, toxic, and expensive and are not available in some endemic regions. Attempts to develop an effective vaccine are feasible, but no vaccine is in active clinical use. In this study, the LmxMBA gene of Leishmania mexicana was selected as a possible vaccine candidate using the reverse vaccinology approach, and the prophylactic effect generated by DNA vaccination with this gene in a murine model of cutaneous leishmaniasis was evaluated. The results showed that prophylactic vaccination with pVAX1::LmxMBA significantly reduced the size of the lesion and the parasitic load on the footpad, compared to the control groups. At a histological level, a smaller number of parasites were evident in the dermis, as well as the absence of connective tissue damage. Mice immunized with plasmid pVAX1::LmxMBA induced immunity characterized by an increase in the IgG2a/IgG1>1 ratio and a higher rate of lymphocyte proliferation. In this study, immunization with the plasmid promoted an improvement in the macroscopic and microscopic clinical manifestations of the experimental infection by L. mexicana, with a T helper 1 response characterized by an IgG2a/IgG1>1 ratio and high lymphoproliferative response. These findings support immunization with the plasmid pVAX1::LmxMBA as a preventive strategy against cutaneous infection of L. mexicana.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available